KRAS and non-small cell lung carcinoma: In five human xenograft models of NSCLC, inhibition of oncogenic KRAS induced downregulation of CXCL1, CXCL8, NT5E and VEGFA mRNA, downregulation of CD274 (PD-L1) mRNA and upregulation of class I MHC.